Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,797 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Razak ARA, Wang HM, Chang JY, Ahn MJ, Munster P, Blumenschein G Jr, Solomon B, Lim DW, Hong RL, Pfister D, Saba NF, Lee SH, van Herpen C, Quadt C, Bootle D, Blumenstein L, Demanse D, Delord JP. Razak ARA, et al. Among authors: chang jy. Target Oncol. 2023 Nov;18(6):853-868. doi: 10.1007/s11523-023-00997-z. Epub 2023 Oct 25. Target Oncol. 2023. PMID: 37875771 Free PMC article. Clinical Trial.
Investigating the association between oral hygiene and head and neck cancer.
Chang JS, Lo HI, Wong TY, Huang CC, Lee WT, Tsai ST, Chen KC, Yen CJ, Wu YH, Hsueh WT, Yang MW, Wu SY, Chang KY, Chang JY, Ou CY, Wang YH, Weng YL, Yang HC, Wang FT, Lin CL, Huang JS, Hsiao JR. Chang JS, et al. Among authors: chang jy, chang ky. Oral Oncol. 2013 Oct;49(10):1010-7. doi: 10.1016/j.oraloncology.2013.07.004. Epub 2013 Aug 13. Oral Oncol. 2013. PMID: 23948049
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial.
Yen CJ, Tsou HH, Hsieh CY, Chu CY, Chiu CF, Chen CC, Tsao CJ, Tsai KY, Tsai ST, Chang JY, Chang KY. Yen CJ, et al. Among authors: chang jy, chang ky. Head Neck. 2019 Jun;41(6):1703-1712. doi: 10.1002/hed.25640. Epub 2019 Jan 12. Head Neck. 2019. PMID: 30636183 Clinical Trial.
Oral hygiene and the overall survival of head and neck cancer patients.
Chang CC, Lee WT, Hsiao JR, Ou CY, Huang CC, Tsai ST, Chen KC, Huang JS, Wong TY, Lai YH, Wu YH, Hsueh WT, Wu SY, Yen CJ, Chang JY, Lin CL, Weng YL, Yang HC, Chen YS, Chang JS. Chang CC, et al. Among authors: chang jy, chang js. Cancer Med. 2019 Apr;8(4):1854-1864. doi: 10.1002/cam4.2059. Epub 2019 Mar 13. Cancer Med. 2019. PMID: 30865385 Free PMC article.
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer.
Ch'ang HJ, Wang CC, Cheng AL, Hsu C, Lu YS, Chang MC, Lin JT, Wang HP, Shiah HS, Liu TW, Chang JY, Whang-Peng J, Chen LT. Ch'ang HJ, et al. Among authors: chang jy, chang mc. J Gastroenterol Hepatol. 2006 May;21(5):874-9. doi: 10.1111/j.1440-1746.2005.04022.x. J Gastroenterol Hepatol. 2006. PMID: 16704539 Clinical Trial.
1,797 results